Serum and tissue tumor growth factor β1 in children with biliary atresia

Journal of Pediatric Surgery

Volumn 45, Issue 9, 2010, Pages 1784-1790

  De Oliveira, Fernanda Dos Santos ^b   Kieling, Carlos Oscar ^a   Dos Santos, Jorge Luiz ^a   De Leon Lima, Patrícia Ponce ^b   Vieira, Sandra ^a   Meurer, Luise ^a,b   Da Silveira, Themis Reverbel ^a,b   Matte, Ursula ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Biliary atresia; Children; Liver; TGF 1

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT ATRESIA; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE COUNT; TISSUE LEVEL;

ASPARTATE AMINOTRANSFERASES; BILIARY ATRESIA; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; COLLAGEN; FEMALE; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; PLATELET COUNT; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956867709     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.04.007     Document Type: Article

References (25)

1. Santos J.L., Kieling C.O., and Meurer L. The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis J Pediatr Surg 44 2009 695 701
2. de Carvalho E., Ivantes C.A., and Bezerra J.A. Extrahepatic biliary atresia: current concepts and future directions J Pediatr (Rio J) 83 2007 105 120
3. Friedman S.L. Hepatic fibrosis-overview Toxicology 254 2008 120 129
4. Gressner O.A., Weiskirchen R., and Gressner A.M. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests Clin Chim Acta 381 2007 107 113
5. Wai C.T., Greenson J.K., and Fontana R.J. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
6. de Ledinghen V., Le Bail B., and Rebouissoux L. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy J Pediatr Gastroenterol Nutr 45 2007 443 450
7. Hardy S., and Kleinman R.E. Cirrhosis and chronic liver failure F.J. Suchy, R.J. Sokal, W.F. Balistreri, Liver disease in children 2001 Lippincott Williams & Wilkins Philadelphia (Pa) 89 128
8. Wiesner R.H. Evidence-based evolution of the MELD/PELD liver allocation policy Liver Transpl. 11 3 2005 261 263
9. Durand F., and Valla D. Assessment of prognosis of cirrhosis Semin Liver Dis 28 1 2008 110 122
10. Masseroli M., Caballero T., and O'Valle F. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis J Hepatol 32 2000 453 464
11. Bissell D.M. Chronic liver injury, TGF-beta, and cancer Exp Mol Med 33 2001 179 190
12. Massague J., and Chen Y.G. Controlling TGF-beta signaling Genes Dev 14 2000 627 644
13. Neumann S., Kaup F.J., and Beardi B. Plasma concentration of transforming growth factor-beta1 and hepatic fibrosis in dogs Can J Vet Res 72 2008 428 431
14. Lebensztejn D.M., Sobaniec-Lotowska M., and Kaczmarski M. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B Hepatogastroenterology 51 2004 229 233 (Pubitemid 38283099)
15. Rosensweig J.N., Omori M., and Page K. Transforming growth factor-beta1 in plasma and liver of children with liver disease Pediatr Res 44 1998 402 409
16. Faiz Kabir Uddin Ahmed A., Ohtani H., and Nio M. In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages J Pathol 192 2000 73 80
17. Lee S.Y., Chuang J.H., and Huang C.C. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia J Pediatr Surg 39 2004 702 708
18. Kaimori A., Potter J., and Kaimori J.Y. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro J Biol Chem 282 2007 22089 22101
19. Ahamed J., Burg N., Yoshinaga K., and Janczak C.A. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1 Blood 112 9 2008 3650 3660
20. Balistreri W.F., Bezerra J.A., and Jansen P. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference Hepatology 42 2005 222 235
21. Richardson M.M., Powell E.E., and Barrie H.D. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C J Med Genet 2005 42 45
22. Wanless I.R. Physioanatomic considerations L. Schiff, E.R. Schiff, Schiff's diseases of the liver 10th ed. 2007 JB Lippincott Philadelphia (PA) 181 212
23. Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases Front Biosci 14 2009 2923 2934
24. Kim I.Y., Kim M.M., and Kim S.J. Transforming growth factor-beta: biology and clinical relevance J Biochem Mol Biol 38 2005 1 8
25. Gressner A.M., and Weiskirchen R. The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply? J Hepatol 39 2003 856 859